Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bayer
Biotech
Bayer-owned BlueRock lays off 50 employees, shuts Cambridge labs
Bayer-owned BlueRock Therapeutics is laying off 50 employees and shuttering its research labs in Cambridge, Mass., a spokesperson said.
James Waldron
Jun 25, 2025 7:46am
Vividion secures clinical-stage WRN inhibitor from Roche
Jun 4, 2025 9:21am
BMS oncology head swings to Syndax—Chutes & Ladders
May 16, 2025 8:30am
Bayer boosts precision oncology efforts with multiyear AI deal
Apr 23, 2025 12:55pm
Bayer moves allogeneic cell therapy into ph. 3 Parkinson's trial
Jan 13, 2025 2:30am
Bayer’s hot flash drug hits goal in phase 3 breast cancer trial
Jan 9, 2025 7:40am
